David M. O'malley MD

Dr. David M. O’Malley, M.D., is the Division Director of Gynecologic Oncology within the Department of Obstetrics and Gynecology and the James Cancer Hospital and Solove Research Institute. Dr. O’Malley is a Professor of Obstetrics and Gynecology. A native of Michigan, he received his B.A. from the University of Notre Dame, M.D. from Wayne State SOM, and completed his residency in OB/Gyn at Case Western Reserve - MetroHealth and the Cleveland Clinic. Dr. O’Malley then completed fellowship training in gynecologic oncology at Yale University before joining the OSU faculty in 2005.

He is active nationally and has served on committees as a member of the Society of Gynecologic Oncology, the Developmental Therapeutics Working Group of the NRG, panel member of the NCCN Guidelines for Ovarian Cancer (2008-2021). Currently, he serves on the Ovarian Cancer Working Group of the NRG, the NCI Gynecologic Cancer Steering Committee's Ovarian Task Force, and in GOG Partners (Ovarian Cancer Clinical Trial Lead). He has been recognized as a Top Doctor since 2010. At OSU, he developed the gynecologic oncology division into one of the premier clinical research and phase I gynecologic oncology programs in the country. He has led numerous clinical trials conducted at the James CCC, including co-PI of the NCI LAPs grant while serving as principal investigator for multiple national and international trials.